<SEC-DOCUMENT>0001213900-20-027951-index.html : 20200923 <SEC-HEADER>0001213900-20-027951.hdr.sgml : 20200923 <ACCEPTANCE-DATETIME>20200923090840 ACCESSION NUMBER: 0001213900-20-027951 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20200921 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200923 DATE AS OF CHANGE: 20200923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 204580525 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 201191059 BUSINESS ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: ArTara Therapeutics, Inc. DATE OF NAME CHANGE: 20200110 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>ea127215-8k_protarathera.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: ea127215-8k_protarathera.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ea127215ex1-1_protara.htm <DESCRIPTION>UNDERWRITING AGREEMENT RELATED TO THE COMMON OFFERING, DATED SEPTEMBER 22, 2020, AMONG PROTARA THERAPEUTICS, INC., COWEN AND COMPANY, LLC AND GUGGENHEIM SECURITIES, LLC <TEXT> Document 2 - file: ea127215ex1-1_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.2 <SEQUENCE>3 <FILENAME>ea127215ex1-2_protara.htm <DESCRIPTION>UNDERWRITING AGREEMENT RELATED TO THE PREFERRED OFFERING, DATED SEPTEMBER 22, 2020, AMONG PROTARA THERAPEUTICS, INC., COWEN AND COMPANY, LLC AND GUGGENHEIM SECURITIES, LLC <TEXT> Document 3 - file: ea127215ex1-2_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>4 <FILENAME>ea127215ex3-1_protara.htm <DESCRIPTION>CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES 1 PREFERRED STOCK OF THE COMPANY <TEXT> Document 4 - file: ea127215ex3-1_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>5 <FILENAME>ea127215ex5-1_protara.htm <DESCRIPTION>OPINION OF COOLEY LLP <TEXT> Document 5 - file: ea127215ex5-1_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>6 <FILENAME>ea127215ex99-1_protara.htm <DESCRIPTION>PRESS RELEASE, DATED SEPTEMBER 21, 2020 <TEXT> Document 6 - file: ea127215ex99-1_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>7 <FILENAME>ea127215ex99-2_protara.htm <DESCRIPTION>PRESS RELEASE, DATED SEPTEMBER 22, 2020 <TEXT> Document 7 - file: ea127215ex99-2_protara.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex5-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: ex5-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: image_001.jpg
</DOCUMENT> </SEC-DOCUMENT>